Vol 62, No 1 (2011)

Date published: 2011-03-01

Table of Contents

open access

paid access

Editorial

EP redaction

Endokrynologia Polska 2011;62(1).
Original papers

Skeletal and functional status in patients with long-standing stroke

Franciszek Pietraszkiewicz, Wojciech Pluskiewicz, Bogna Drozdzowska

Endokrynologia Polska 2011;62(1):2-7.

Forearm SXA densitometry in 1,122 Polish women - a cohort study

Marek Bolanowski, Aleksandra Jawiarczyk, Diana Jędrzejuk, Andrzej Milewicz

Endokrynologia Polska 2011;62(1):8-13.

Switching from one generic alendronate to another - a common procedure in Poland in the years 2001-2005

Edward Franek, Marek Tałałaj, Hanna Wichrowska, Beata Czerwieńska, Rafał Filip, Krzysztof Safranow, Ewa Marcinowska-Suchowierska, Andrzej Więcek

Endokrynologia Polska 2011;62(1):14-17.

Histological changes in the epiphyseal plate of growing young adult male rats after long-term hydrocortisone and salmon calcitonin administration

Mirosław Jabłoński, Karolina Turżańska, Mieczysław Gorzelak, Grażyna Orlicz-Szczęsna

Endokrynologia Polska 2011;62(1):18-23.

Alendronate 70 therapy in elderly women with post-menopausal osteoporosis: the problem of compliance

Ewa Sewerynek, Bogdan Małkowski, Ewa Karzewnik, Wioletta Stepien-Klos, Maria Tabaszewska, Marek Lasota, Grażyna Krupińska, Anna Glądalska, Wanda Horst-Sikorska, Michał Stuss

Endokrynologia Polska 2011;62(1):24-32.

A discussion of the intervention thresholds in osteoporosis treatment in Poland

Michalina Marcinkowska, Magdalena Ignaszak-Szczepaniak, Anna Wawrzyniak, Joanna Dytfeld, Wanda Horst-Sikorska

Endokrynologia Polska 2011;62(1):30-36.
Review article

The role of anorexia nervosa in secondary osteoporosis development with the risk for low energy fractures

Wanda Horst-Sikorska, Magdalena Ignaszak-Szczepaniak

Endokrynologia Polska 2011;62(1):45-47.

Skeletal consequences in patients after stroke

Wojciech Pluskiewicz

Endokrynologia Polska 2011;62(1):48-50.

The role of i.v. ibandronate administration in osteoporosis therapy

Ewa Sewerynek, Michał Stuss

Endokrynologia Polska 2011;62(1):51-60.

The role of hormonal therapy in osteoporosis

Wanda Horst-Sikorska, Anna Wawrzyniak

Endokrynologia Polska 2011;62(1):61-64.

Strontium ranelate in post-menopausal osteoporosis

Jerzy Przedlacki

Endokrynologia Polska 2011;62(1):65-72.

Denosumab - a new option in the treatment of osteoporosis

Edward Franek

Endokrynologia Polska 2011;62(1):79-83.

Atypical subtrochanteric fractures after long-term bisphosphonate therapy

Edward Czerwiński

Endokrynologia Polska 2011;62(1):84-87.

Osteonecrosis of the jaw

Bogna Drozdzowska

Endokrynologia Polska 2011;62(1):88-92.

Bisphosphonates and the risk of atrial fibrillation

Ewa Sewerynek, Michał Stuss

Endokrynologia Polska 2011;62(1):93-96.
Letter to Editor. Informations about scientific co...

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl